471 related articles for article (PubMed ID: 31100227)
21. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
22. Patient-reported outcome measures after treatment for prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata).
Nguyen-Nielsen M; Møller H; Tjønneland A; Borre M
Cancer Epidemiol; 2020 Feb; 64():101623. PubMed ID: 31760356
[TBL] [Abstract][Full Text] [Related]
23. Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study.
Wilding S; Downing A; Selby P; Cross W; Wright P; Watson EK; Wagland R; Kind P; Donnelly DW; Hounsome L; Mottram R; Allen M; Kearney T; Butcher H; Gavin A; Glaser A
Psychooncology; 2020 May; 29(5):886-893. PubMed ID: 32065691
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life, Psychological Functioning, and Treatment Satisfaction of Men Who Have Undergone Penile Prosthesis Surgery Following Robot-Assisted Radical Prostatectomy.
Pillay B; Moon D; Love C; Meyer D; Ferguson E; Crowe H; Howard N; Mann S; Wootten A
J Sex Med; 2017 Dec; 14(12):1612-1620. PubMed ID: 29111200
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
26. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
[TBL] [Abstract][Full Text] [Related]
27. Satisfaction with Nurse-led Follow-up in Prostate Cancer Patients-A Nationwide Population-based Study.
Bergengren O; Kaihola H; Borgefeldt AC; Johansson E; Garmo H; Bill-Axelson A
Eur Urol Open Sci; 2022 Apr; 38():25-31. PubMed ID: 35495287
[TBL] [Abstract][Full Text] [Related]
28. The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.
Oake JD; Harasemiw O; Tangri N; Ferguson TW; Saranchuk JW; Bansal RK; Drachenberg DE; Nayak JG
J Urol; 2021 Nov; 206(5):1204-1211. PubMed ID: 34181467
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of patient navigation programs for adult cancer patients undergoing treatment: a systematic review.
Tho PC; Ang E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):295-321. PubMed ID: 27536800
[TBL] [Abstract][Full Text] [Related]
30. Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes.
Imnadze M; Sjoberg DD; Vickers AJ
Eur Urol; 2016 Jan; 69(1):143-8. PubMed ID: 25913389
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.
Venderbos LDF; Aluwini S; Roobol MJ; Bokhorst LP; Oomens EHGM; Bangma CH; Korfage IJ
Qual Life Res; 2017 Jun; 26(6):1635-1645. PubMed ID: 28168601
[TBL] [Abstract][Full Text] [Related]
32. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry.
Cuypers M; Lamers RED; de Vries M; Husson O; Kil PJM; van de Poll-Franse LV
Urol Oncol; 2016 Nov; 34(11):482.e11-482.e18. PubMed ID: 27432432
[TBL] [Abstract][Full Text] [Related]
34. Radical prostatectomy versus watchful waiting for prostate cancer.
Hegarty J; Beirne PV; Walsh E; Comber H; Fitzgerald T; Wallace Kazer M
Cochrane Database Syst Rev; 2010 Nov; (11):CD006590. PubMed ID: 21069689
[TBL] [Abstract][Full Text] [Related]
35. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
36. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study.
Plym A; Clements M; Voss M; Holmberg L; Stattin P; Lambe M
BMJ Open; 2020 Mar; 10(3):e032914. PubMed ID: 32156761
[TBL] [Abstract][Full Text] [Related]
37. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
38. Active treatment in low-risk prostate cancer: a population-based study.
Roy S; Hyndman ME; Danielson B; Fairey A; Lee-Ying R; Cheung WY; Afzal AR; Xu Y; Abedin T; Quon HC
Curr Oncol; 2019 Aug; 26(4):e535-e540. PubMed ID: 31548822
[TBL] [Abstract][Full Text] [Related]
39. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
40. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]